Abstract: The present invention relates to an ophthalmic composition of Brinzolamide. More particularly, the present invention relates to an ophthalmic solution of Brinzolamide comprising Brinzolamide dispersed uniformly in a polymer in form of polymeric micelles. Further, the present invention relates to aqueous micelle solutions of Brinzolamide which provide a sustained Intra Ocular Pressure lowering effect. Further, the present invention relates to aqueous micelle solutions of Brinzolamide which are more bioavailable, efficacious and also provide a sustained Intra Ocular Pressure (IOP) lowering effect than, the currently marketed ophthalmic suspensions of Brinzolamide. The present invention also relates to stable ophthalmic aqueous micelle solutions of Brinzolamide.
| # | Name | Date |
|---|---|---|
| 1 | 202417096144-TRANSLATIOIN OF PRIOIRTY DOCUMENTS ETC. [05-12-2024(online)].pdf | 2024-12-05 |
| 2 | 202417096144-STATEMENT OF UNDERTAKING (FORM 3) [05-12-2024(online)].pdf | 2024-12-05 |
| 3 | 202417096144-POWER OF AUTHORITY [05-12-2024(online)].pdf | 2024-12-05 |
| 4 | 202417096144-NOTIFICATION OF INT. APPLN. NO. & FILING DATE (PCT-RO-105-PCT Pamphlet) [05-12-2024(online)].pdf | 2024-12-05 |
| 5 | 202417096144-FORM 1 [05-12-2024(online)].pdf | 2024-12-05 |
| 6 | 202417096144-DRAWINGS [05-12-2024(online)].pdf | 2024-12-05 |
| 7 | 202417096144-DECLARATION OF INVENTORSHIP (FORM 5) [05-12-2024(online)].pdf | 2024-12-05 |
| 8 | 202417096144-COMPLETE SPECIFICATION [05-12-2024(online)].pdf | 2024-12-05 |
| 9 | 202417096144-Proof of Right [26-12-2024(online)].pdf | 2024-12-26 |
| 10 | 202417096144-FORM 18 [26-12-2024(online)].pdf | 2024-12-26 |